ANALYSIS OF CLINICAL-MORPHOLOGICAL INDICATORS AT DEVELOPMENT OF EARLY RELAPSES IN PATIENTS WITH INITIALLY OPERABLE BREAST CANCER
https://doi.org/10.51523/2708-6011.2009-6-3-5
Abstract
We studied the major clinical-diagnostic indicators with different clinical outcomes of breast cancer. We show that early disease progression (up to 3 years) is defined by tumor size, lymph nodes metastases, high histological degree of malignancy, age at the moment of disease, as well as the combination of sex hormone receptors.
About the Author
E. A. Nadyrov
Republican Research Center for Radiation Medicine and Human Ecology
Belarus
Belarus
References
1. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials / M. Clarke [et al.] // Lancet. - 2005. - Vol. 366, № 9503. - P. 2087-2106.
2. Dinshaw, K. A. Profile of prognostic factors in 1022 Indian women with early-stage breast cancer treated with breast-conserving therapy / K. A. Dinshaw, A. N. Budrukkar, R. F. Chinoy // Int. J. Radiat. Oncol. Biol. Phys. - 2005. - Vol. 63, № 4. - P. 1132-1141.
3. The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: How young is «young»? / J. L. Oh [et al.] // Int. J. Radiat. Oncol. Biol. Phys. - 2006. - Vol. 65, № 5. - P. 1345-1352.
4. Patterns of Locoregional Failure in Patients With Operable Breast Cancer Treated by Mastectomy and Adjuvant Chemotherapy With or Without Tamoxifen and Without Radiotherapy: Results From Five National Surgical Adjuvant Breast and Bowel Project Randomized Clinical Trials / A. Taghian [et al.] // J. Clin. Oncol. - 2004. - Vol. 15. - P. 4247-4254.
5. Летягин, В. П. Органосохраняющие операции в комплексном лечении больных раком молочной железы / В. П. Летягин, Н. Н. Волченко // Рос. онкол. журн. - 2001. - № 4. - С. 4-6.
6. Breast conservation after neoadjuvant chemotherapy: The M. D. Anderson cancer center experience / A. M. Chen [et al.] // J. Clin. Oncol. - 2004. - Vol. 22. - P. 2303-2312.
7. Dinshaw, K. A. Profile of prognostic factors in 1022 Indian women with early-stage breast cancer treated with breast-conserving therapy / K. A. Dinshaw, A. N. Budrukkar, R. F. Chinoy // Int. J. Radiat. Oncol. Biol. Phys. - 2005. - Vol. 63, № 4. - P. 1132-1141.
8. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy / P. T. Truong [et al.] // J. Am. Coll. Surg. - 2005. - Vol. 2000, № 6. - P. 912-921.
9. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII / A. Wallgren [et al.] // J. Clin. Oncol. - 2003. - Vol. 21, № 7. - P. 1205-1213.
10. Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases / V. J. Bardou [et al.] // J. Clin. Oncol. - 2003. - Vol. 21. - P. 1973-1979.
11. Estrogen receptor positive (ER+), progesterone receptor negative (PgR-) breast cancer: new insights into molecular mechanisms and clinical implications / G. Arpino [et al.] // Breast cancer research and treatment. 27Ih Annual San Antonio breast cancer symposium. - 2004. - Vol. 88. - Р. 105.
12. Божок, А. А. Прогностические и предсказующие факторы при раке молочной железы / А. А Божок. // Матер. IV междунар. ежегодной конф. «Проблемы диагностики и лечения рака молочной железы». - М., 2007. - С. 26
Review
For citations:
Nadyrov E.A. ANALYSIS OF CLINICAL-MORPHOLOGICAL INDICATORS AT DEVELOPMENT OF EARLY RELAPSES IN PATIENTS WITH INITIALLY OPERABLE BREAST CANCER. Health and Ecology Issues. 2009;(3):26-29. (In Russ.) https://doi.org/10.51523/2708-6011.2009-6-3-5
Views: 218
Email this article 